Le Lézard
Classified in: Science and technology
Subject: Proxy/Proxy Vote

Leopard Asset Management Expresses Concerns Over Sun Corporation's Lack of Action to Enhance Shareholder Value


Leopard Asset Management Ltd. ("LAM") advises various longstanding minority shareholders in Sun Corporation (stock code: 6736 JP). LAM is compelled to express its deep concerns regarding the company's ongoing undervaluation and management's apparent reluctance to take meaningful action to address this issue.

Sun's shares have been consistently undervalued in the market, trading well below its intrinsic value. Sun's main asset is its 47% stake in Cellebrite Technologies (NASDAQ: CLBT). Cellebrite is a leading Israeli SaaS digital intelligence platform renowned for its capability to extract and analyze data from mobile phones. Sun's shares have been trading consistently at discount in excess of 50% of their interstice value.

Despite our repeated attempts to engage with Sun' management to address the undervaluation, including a meeting and sending follow-up letters emphasizing the need for enhanced shareholder value, our efforts have been met with limited responsiveness.

LAM believes that Sun could significantly improve shareholder value by distributing CLBT shares as a dividend in kind, alongside providing an extra cash dividend to shareholders. LAM believes Sun's cash, investment in securities and holdings in CLBT are worth more than ¥9,000 per share, vs. the current price of ¥3,320.

LAM urge Sun's management to reconsider its stance and take decisive action to address shareholder concerns promptly. Failure to do so risks further erosion of shareholder confidence and continued undervaluation of the company's shares, and call for Sun's shareholders to demand decisive actions from management.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: